BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 12924663)

  • 21. Hyperlipasemia associated with hepatitis C virus.
    Yoffe B; Bagri AS; Tran T; Dural AT; Shtenberg KM; Khaoustov VI
    Dig Dis Sci; 2003 Aug; 48(8):1648-53. PubMed ID: 12924663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
    Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
    Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C.
    Chaudhari S; Park J; Anand BS; Pimstone NR; Dieterich DT; Batash S; Bini EJ
    Dig Dis Sci; 2004 Jun; 49(6):1000-6. PubMed ID: 15309891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C infection in African Americans: its natural history and histological progression.
    Wiley TE; Brown J; Chan J
    Am J Gastroenterol; 2002 Mar; 97(3):700-6. PubMed ID: 11922566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy.
    McHutchison JG; Shad JA; Gordon SC; Morgan TR; Ling MH; Garaud JJ; Albrecht JK; Dienstag JL
    J Viral Hepat; 2001 Nov; 8(6):414-20. PubMed ID: 11703572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In situ detection of hepatitis C virus RNA in salivary glands.
    Arrieta JJ; Rodríguez-Iñigo E; Ortiz-Movilla N; Bartolomé J; Pardo M; Manzarbeitia F; Oliva H; Macías DM; Carreño V
    Am J Pathol; 2001 Jan; 158(1):259-64. PubMed ID: 11141499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of markers of hepatitis C virus infection throughout the body.
    Gowans EJ
    Semin Liver Dis; 2000; 20(1):85-102. PubMed ID: 10895434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute pancreatitis attributed to the use of interferon alfa-2b.
    Eland IA; Rasch MC; Sturkenboom MJ; Bekkering FC; Brouwer JT; Delwaide J; Belaiche J; Houbiers G; Stricker BH
    Gastroenterology; 2000 Jul; 119(1):230-3. PubMed ID: 10889173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute hepatitis C complicated by pancreatitis: another extrahepatic manifestation of hepatitis C virus?
    Alvares-Da-Silva MR; Francisconi CF; Waechter FL
    J Viral Hepat; 2000 Jan; 7(1):84-6. PubMed ID: 10718948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.
    Cacoub P; Renou C; Rosenthal E; Cohen P; Loury I; Loustaud-Ratti V; Yamamoto AM; Camproux AC; Hausfater P; Musset L; Veyssier P; Raguin G; Piette JC
    Medicine (Baltimore); 2000 Jan; 79(1):47-56. PubMed ID: 10670409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extrahepatic manifestations of HCV infection: facts and controversies.
    Zignego AL; Bréchot C
    J Hepatol; 1999 Aug; 31(2):369-76. PubMed ID: 10453955
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum pancreatic enzyme concentrations in chronic viral liver diseases.
    Pezzilli R; Andreone P; Morselli-Labate AM; Sama C; Billi P; Cursaro C; Barakat B; Gramenzi A; Fiocchi M; Miglio F; Bernardi M
    Dig Dis Sci; 1999 Feb; 44(2):350-5. PubMed ID: 10063922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues.
    Laskus T; Radkowski M; Wang LF; Vargas H; Rakela J
    Hepatology; 1998 Nov; 28(5):1398-401. PubMed ID: 9794927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C: the clinical spectrum of disease.
    Hoofnagle JH
    Hepatology; 1997 Sep; 26(3 Suppl 1):15S-20S. PubMed ID: 9305658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic hepatitis C.
    Sharara AI
    South Med J; 1997 Sep; 90(9):872-7. PubMed ID: 9305294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PCR detected hepatitis C virus genome in the brain of a case with progressive encephalomyelitis with rigidity.
    Bolay H; Söylemezoğlu F; Nurlu G; Tuncer S; Varli K
    Clin Neurol Neurosurg; 1996 Nov; 98(4):305-8. PubMed ID: 9081776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild pancreatic damage in acute viral hepatitis.
    Taranto D; Carrato A; Romano M; Maio G; Izzo CM; Del Vecchio Blanco C
    Digestion; 1989; 42(2):93-7. PubMed ID: 2475380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.